International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2021 - Volume 25, Number 3
View All Articles in Issue

Page(s): 233

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, naltrexone hydrochloride, narcotic opioid antagonist, methadone maintenance, opioid overdose

Related Categories: FORMULATIONS, MENTAL HEALTH

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 233
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Naltrexone Hydrochloride 50-mg Capsules Allen Loyd V Jr	May/Jun 2013 Pg. 235
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A	Mar/Apr 2019 Pg. 157-162
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Compounding Naltrexone for the Treatment of Autism Wynn Tom, Brunetti Sarah	Jul/Aug 2009 Pg. 296-299
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Opioids: A Review of the Pharmacology Ford Peter R	Jan/Feb 2000 Pg. 17-20
Naltrexone 1-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 459
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don	Jul/Aug 2018 Pg. 270-278
Naloxone Hydrochloride 1-mg/mL Injection Allen Loyd V Jr	May/Jun 2012 Pg. 244
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Allen Loyd V Jr	Nov/Dec 2011 Pg. 504
Chemical Stability of Naltrexone Hydrochloride Injection Gupta Vishnu D	May/Jun 2008 Pg. 274-275
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free Allen Loyd V Jr	Jan/Feb 2005 Pg. 67
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Sturn Kayla M, Collin Michael	May/Jun 2016 Pg. 197-201
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 239
Return to Top